glp-1 and cancer risk Long-term in users of agonists in Denmark: a nationwide emulated trial GLP-1RA and thyroid cancer: New
Description
Copper sulfide (CuS) nanosheets coated with membrane-degradable polymers have been developed to enhance deep brain tumor penetration by modulating intercellular interactions
Skofitsch, G., Wimalawansa, S
These drugs, acting as agonists of Glucagon-like Peptide-1 receptor (GLP-1R), are recognized for promoting insulin secretion, suppressing glucagon release, and delaying gastric emptying [1]
Yammine, L
The active ingredients are sourced from FDA-registered facilities, though finished formulations and delivery mechanisms differ
